BNTX
BioNTech SE · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +8.3% ·
share flow -0.6% ·
net new positions +7.7%
· formula
Ownership fragmentation: more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 760.71K | $74.78M | n/a | −2 |
| Q2 2026 | 92 | 0 | 32.20M | $3.00B | +8 | −10 |
| Q1 2026 | 95 | +4 | 29.16M | $2.59B | +13 | −9 |
| Q4 2025 | 91 | +4 | 29.39M | $2.80B | +4 | n/a |
| Q3 2025 | 13 | +1 | 23.37M | $2.30B | +1 | n/a |
| Q2 2025 | 9 | -3 | 22.65M | $2.41B | +1 | −4 |
| Q1 2025 | 10 | -2 | 14.39M | $1.31B | n/a | −2 |
| Q4 2024 | 12 | -1 | 14.53M | $1.66B | +1 | −2 |
| Q3 2024 | 12 | +1 | 13.93M | $1.65B | +3 | −2 |
| Q2 2024 | 11 | n/a | 15.47M | $1.24B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 7.88M | -2.0% | $777.06M | 0.6% | ▼ Trim | 6 | SEC ↗ ×5 |
| 2 | Fidelity (FMR) ✦ | 5.45M | -33.2% | $537.82M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | PRIMECAP Management ✦ | 3.87M | -3.3% | $381.73M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 4 | Dodge & Cox ✦ | 3.65M | +315.6% | $359.68M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 765.31K | -41.8% | $75.47M | 0.0% | ▼ Trim | 2 | SEC ↗ ×11 |
| 6 | Morgan Stanley ✦ | 603.02K | n/a | $59.47M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 7 | Citadel Advisors ✦ | 389.50K | +14261.9% | $38.41M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 246.33K | New | $24.29M | 0.0% | New | 1 | SEC ↗ |
| 9 | Goldman Sachs Group ✦ | 146.58K | n/a | $14.46M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | State Street Global Advisors ✦ (passive) | 126.64K | -12.8% | $12.49M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | JPMorgan Chase ✦ | 120.31K | n/a | $11.87M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 12 | Geode Capital Management ✦ (passive) | 115.99K | +11.8% | $11.44M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | Marshall Wace ✦ | 3.54K | -26.8% | $346,134 | 0.0% | ▼ Trim | 6 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Millennium Management | $24.29M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 272 holders, 47.28M shares, $3.59B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, 10% owner · 36.21K sh · $3.45M
Officer, 10% owner · 27.00K sh · $2.49M
Officer, 10% owner · 24.00K sh · $2.30M
Officer, 10% owner · 21.00K sh · $2.03M
Officer, 10% owner · 72.00K sh · $7.00M
Officer, 10% owner · 17.00K sh · $1.64M
Officer, 10% owner · 17.00K sh · $1.66M
Officer, 10% owner · 32.00K sh · $3.14M
Officer, 10% owner · 34.00K sh · $3.34M
Officer, 10% owner · 34.00K sh · $3.35M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology